Skyrizi (risankizumab)

$3,742.32

IL-23 inhibitor for psoriasis

SKU: skyrizi-risankizumab Category: Tags: , , ,

Description

Skyrizi (risankizumab) is a monoclonal antibody targeting IL-23 for the treatment of plaque psoriasis.

Reviews

There are no reviews yet.

Be the first to review “Skyrizi (risankizumab)”

Your email address will not be published. Required fields are marked *